Background Congenital cytomegalovirus (cCMV) is the most common congenital infection
worldwide. cCMV can lead to severe long‐term sequelae, including neurological impairment …

Objectives: Cytomegalovirus (CMV) infection is a significant health concern affecting
numerous expectant mothers across the globe. CMV is the leading cause of health problems …

The objective of this review was to bring to attention cytomegalovirus (CMV) infection during
pregnancy, taking into consideration all relevant aspects, such as maternal diagnosis, fetal …

Cytomegalovirus infection is the most common congenital infection, affecting about 1% of
births worldwide. Several primary, secondary, and tertiary prevention strategies are already …

Targeted screening is widely recommended as standard of care, while universal screening
is less common but is progressively considered as the optimal strategy for identification of …

Objective Maternal and fetal congenital infection by cytomegalovirus (CMV) during
pregnancy is the leading infectious cause of neurologic impairment and hearing loss. Efforts …

Purpose of review There have been recent advances in the field of congenital CMV infection
(cCMV) related to antiviral treatment of pregnant women and infants, the implementation of …

Objectives Cytomegalovirus (CMV) is the leading cause of congenital infection worldwide.
Reference anti-CMV treatment is valganciclovir/ganciclovir, which is contraindicated in …

Cytomegalovirus (CMV) infection during pregnancy is a global silent problem. Additionally, it
is the leading cause of congenital infections, non-genetic sensorineural hearing loss, and …

A vaccine to prevent congenital cytomegalovirus infection (cCMV) is a public health priority.
cCMV results from maternal primary or non-primary CMV infection (reinfection, or …